潜在的使用抗codon工程tRNAs (ACE-tRNAs) 治疗无意义的变体导致遗传性视网膜疾病
Asodu Sandeep Sarma1, Dror Sharon1
1Division of Ophthalmology, Hadassah Medical Center, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.
Molecular aspects of medicine
|December 30, 2025
概括
抗子工程tRNAs (ACE-tRNAs) 为早期终止子变异引起的遗传视网膜疾病 (IRDs) 提供了一个有希望的新疗法,目前缺乏有效的治疗方法.
科学领域:
- 眼科医生 眼科 眼科
- 遗传学 是一个遗传学.
- 分子生物学分子生物学
背景情况:
- 遗传性视网膜疾病 (IRD) 是导致失明的首要原因,全球约有3450人中有1人受到影响.
- 超过350个基因与IRD相关,具有各种遗传模式.
- 无意义变异,导致过早终止子 (PTCs),占IRD引起突变的约18%,缺乏有效的治疗方法.
研究的目的:
- 审查无意义变体在IRD中的作用.
- 检查针对IRDs的抗子工程tRNA (ACE-tRNA) 治疗的治疗潜力.
- 讨论ACE-tRNA疗法的机制,进展,优势和局限性.
主要方法:
- 在IRD中对基因变异的文献综述.
- 对ACE-tRNA技术进行无意义突变阅读的分析.
- 批判性评估当前的研究和临床潜力.
主要成果:
- 无意义的变异是IRDs的重要遗传原因.
- 通过抑制PTCs,ACE-tRNAs显示出恢复蛋白质功能的潜力.
- 该综述综合了关于ACE-tRNA治疗IRDs的现有知识.
结论:
- ACE-tRNA疗法代表了治疗无意义变异引起的IRD的有希望的策略.
- 需要进一步的研究和开发来克服局限性并推进ACE-tRNA疗法.
- 这种方法有可能解决IRD治疗的重大未满足需求.
更多相关视频
06:58Loss-of-Function Approach in the Embryonic Chick Retina by Using Tol2 Transposon-Mediated Transgenic Expression of Artificial microRNAs
Published on: May 18, 2022
1.4K
07:04Electroporation-Based Genetic Modification of Primary Human Pigment Epithelial Cells Using the Sleeping Beauty Transposon System
Published on: February 4, 2021
2.4K
相关概念视频
Nonsense-mediated mRNA Decay
11.6K
The Upf proteins that carry out nonsense-mediated decay (NMD) are found in all eukaryotic organisms, including humans. Each protein has an individual role, but they need to work in collaboration. Upf1 is an ATP-dependent RNA helicase that unwinds the RNA helix. Because Upf1 can unwind any RNA, Upf2 and Upf3 are required to help Upf1 discriminate between nonsense and normal mRNAs.
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
11.6K
Nonsense-mediated mRNA Decay
3.2K
3.2K
Translation
17.4K
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteins are...
Translation Produces the Building Blocks of Life
Proteins are...
17.4K
Translation
154.9K
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
154.9K
Experimental RNAi
7.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
7.2K
Mutations
94.2K
Overview
94.2K
